Palisade Bio (PALI) Interest Coverage Ratio (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -115.37% |
| Dec 31, 2025 | -753.95% |
| Sep 30, 2025 | 58.89% |
| Jun 30, 2025 | 38.46% |
| Mar 31, 2025 | -104.91% |
| Dec 31, 2024 | -88.25% |
| Sep 30, 2024 | 71.56% |
| Jun 30, 2024 | 42.68% |
| Mar 31, 2024 | -365.82% |
| Dec 31, 2023 | -66.97% |
| Sep 30, 2023 | 60.74% |
| Dec 31, 2022 | -16.26% |
| Sep 30, 2022 | -54.43% |
| Jun 30, 2022 | 81.63% |
| Mar 31, 2022 | -382.74% |
| Dec 31, 2021 | -594.31% |
| Sep 30, 2021 | -131.24% |
| Jun 30, 2021 | -4,292.64% |
| Mar 31, 2021 | 93.10% |
| Dec 31, 2020 | 74.47% |
| Sep 30, 2020 | 70.33% |
| Jun 30, 2020 | 71.67% |
| Mar 31, 2020 | -62.24% |
| Dec 31, 2019 | 57.16% |
| Sep 30, 2019 | 70.65% |
| Jun 30, 2019 | -210.67% |
| Mar 31, 2019 | -136.73% |
| Dec 31, 2018 | 62.99% |
| Sep 30, 2018 | 46.94% |
| Jun 30, 2018 | -114.19% |
| Mar 31, 2018 | -73.78% |
| Dec 31, 2017 | 62.38% |
| Sep 30, 2017 | -597.69% |
| Jun 30, 2017 | -779.20% |
| Mar 31, 2017 | -3.58% |
| Dec 31, 2016 | -44.02% |
| Sep 30, 2016 | -71.94% |
| Jun 30, 2016 | 26.26% |
| Mar 31, 2016 | -62.79% |
| Dec 31, 2015 | 11.52% |
| Sep 30, 2015 | -2.91% |
| Jun 30, 2015 | -7.02% |
| Mar 31, 2015 | 6.07% |
| Dec 31, 2014 | 4.70% |
| Sep 30, 2014 | -28.60% |
| Jun 30, 2014 | 26.18% |
| Mar 31, 2014 | -98.25% |
| Dec 31, 2013 | 25.45% |
| Sep 30, 2013 | -9.89% |
| Jun 30, 2013 | 87.71% |
| Mar 31, 2013 | 98.00% |
| Dec 31, 2012 | 61.14% |
| Sep 30, 2012 | -94.45% |
| Jun 30, 2012 | -37.32% |
| Mar 31, 2012 | 7.46% |
| Dec 31, 2010 | 100.02% |
| Sep 30, 2010 | -194.06% |